The Role of Wnt Signalling in Chronic Kidney Disease (CKD)

被引:24
|
作者
Malik, Soniya A. [1 ]
Modarage, Kavindiya [1 ]
Goggolidou, Paraskevi [1 ]
机构
[1] Univ Wolverhampton, Fac Sci & Engn, Dept Biomed Sci & Physiol, Wulfruna St, Wolverhampton WV1 1LY, England
关键词
Wnt signalling; polycystic kidney disease; nephronophthisis; beta-catenin; planar cell polarity signalling; PLANAR CELL POLARITY; FOCAL SEGMENTAL GLOMERULOSCLEROSIS; MOLECULAR-CLONING; BETA-CATENIN; JOUBERT-SYNDROME; PROTEIN; URETERAL OBSTRUCTION; ABERRANT ACTIVATION; WIDE ASSOCIATION; GENE;
D O I
10.3390/genes11050496
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Chronic kidney disease (CKD) encompasses a group of diverse diseases that are associated with accumulating kidney damage and a decline in glomerular filtration rate (GFR). These conditions can be of an acquired or genetic nature and, in many cases, interactions between genetics and the environment also play a role in disease manifestation and severity. In this review, we focus on genetically inherited chronic kidney diseases and dissect the links between canonical and non-canonical Wnt signalling, and this umbrella of conditions that result in kidney damage. Most of the current evidence on the role of Wnt signalling in CKD is gathered from studies in polycystic kidney disease (PKD) and nephronophthisis (NPHP) and reveals the involvement of beta-catenin. Nevertheless, recent findings have also linked planar cell polarity (PCP) signalling to CKD, with further studies being required to fully understand the links and molecular mechanisms.
引用
收藏
页数:19
相关论文
共 50 条
  • [41] Vitamin D resistance in chronic kidney disease (CKD)
    Amay Parikh
    Herbert S Chase
    Linda Vernocchi
    Leonard Stern
    BMC Nephrology, 15
  • [42] Vitamin D and methylarginines in chronic kidney disease (CKD)
    Torino, Claudia
    Pizzini, Patrizia
    Cutrupi, Sebastiano
    Tripepi, Rocco
    Tripepi, Giovanni
    Mallamaci, Francesca
    Zoccali, Carmine
    PLOS ONE, 2017, 12 (10):
  • [43] COPING IN YOUNG PEOPLE WITH CHRONIC KIDNEY DISEASE (CKD)
    Muhammad, Shahid
    Milford, David V.
    Carson, Amanda
    Young, Harry
    Martin, Colin R.
    JOURNAL OF RENAL CARE, 2016, 42 (01) : 34 - 42
  • [44] Predicted prevalence in Japan of chronic kidney disease (CKD)
    Genjiro Kimura
    Clinical and Experimental Nephrology, 2007, 11 (2) : 188 - 189
  • [45] SERUM POTASSIUM AND OUTCOMES IN CHRONIC KIDNEY DISEASE (CKD)
    Nakhoul, Georges N.
    Arrigain, Susana
    Schold, Jesse D.
    Nally, Joseph V.
    Navaneethan, Sankar D.
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2015, 65 (04) : A59 - A59
  • [46] Prevalence of chronic kidney disease (CKD) in the hospital setting
    Barlev, Arie
    Thornton, Sidney
    Holmen, John
    Bower, Anthony G.
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2008, 51 (04) : A33 - A33
  • [47] Etiology of Chronic Kidney Disease (CKD) in Saudi Arabia
    Ahmed, Hussain Gadelkarim
    Alzayed, Faisal Saud Mohammed
    Albluwe, Husam Khalaf Ali
    Alosayfir, Ziyad Ali Salem
    Aljarallah, Mohannad Yousef Jarallah
    Alghazi, Besher Kanan M.
    Alshammari, Mohammed Ali Ghazal
    INTERNATIONAL JOURNAL OF MEDICAL RESEARCH & HEALTH SCIENCES, 2019, 8 (05): : 177 - 182
  • [48] Monogenic and polygenic concepts in chronic kidney disease (CKD)
    Jefferis, Julia
    Hudson, Rebecca
    Lacaze, Paul
    Bakshi, Andrew
    Hawley, Carmel
    Patel, Chirag
    Mallett, Andrew
    JOURNAL OF NEPHROLOGY, 2024, 37 (01) : 7 - 21
  • [49] Chronic kidney disease Alternative view of CKD and QOF
    Connor, Andrew
    O'Donoghue, Donal
    BRITISH MEDICAL JOURNAL, 2010, 341
  • [50] Regulation of parathyroid function in chronic kidney disease (CKD)
    Fukagawa M.
    Nakanishi S.
    Fujii H.
    Hamada Y.
    Abe T.
    Clinical and Experimental Nephrology, 2006, 10 (3) : 175 - 179